Comparison Can-Fite Biopharma (CANF) with Competitors
Can-Fite Biopharma (CANF) industry is Biotechnology.
Operating Margin
CANF-2489.00%
Industry-2073.25%
Upside-415.75%
Debt-to-Equity
CANF1.27%
Industry29.76%
Upside-95.73%
Free Cash Flow Yield
CANF-94.97%
Industry-1.94%
Upside-93.02%
P/E
CANF-3.76
Industry-18.88
Upside+1511.92%
Forward P/E
CANF2.97
Industry15.43
Upside-80.78%
P/S
CANF17.72
Industry9.28
Upside+90.90%
P/B
CANF1.32
Industry4.70
Upside-71.94%